Ethiopia: Our Impact

 {Photo credit: Warren Zelman}Ethiopia is making progress in tackling tuberculosis, the leading infectious disease killer along with HIV.Photo credit: Warren Zelman

This week, MSH is joining researchers, advocates, civil society, scientists, healthcare professionals, and students working on all aspects of lung health around the world in Guadalajara, Mexico for the 48th Union World Conference on Lung Health, where tuberculosis is the key topic. Tuberculosis (TB) is one of the top 10 causes of death worldwide, with over 95% of TB deaths occurring in low- and middle-income countries. Although tremendous progress has been made in the ongoing fight against this disease, some key segments of the population continue to shoulder the burden of TB more acutely.

{Photo Credit: Tsion Issayas/MSH}    Consortium members of Community HIV Care and Treatment Project, USAID Mission Director and the State Minister of Health hand in hand for a successful partnership.Photo Credit: Tsion Issayas/MSH

The Community HIV Care and Treatment Project in Ethiopia was launched on September 19, 2017. The event was attended by the State Minister of Health Dr. Kebede Worku, USAID’S Mission Director Leslie Reed, consortium members, and implementing partners.

 {Graphic: African Strategies for Health}Officials from nine African countries convened in Ghana to find solutions to common challenges of attaining universal health coverage (UHC) with sustainability and improved quality of care.Graphic: African Strategies for Health

by African Strategies for Health The goals of universal health coverage (UHC) can only be delivered when access to health services and financial risk protection are equitably addressed.

{Photo Credit: MSH Staff}Photo Credit: MSH Staff

Management Sciences for Health has been working closely in collaboration with the Global Alliance for TB Drug Development (TB Alliance) on the introduction of the new dispersible pediatric fixed-dose combination. Through MSH’s projects across identified high-burden countries, we have been providing assistance on updating treatment guidelines and essential medicines lists, registration of the reformulated product, financing and reprogramming grants, quantification, and training healthcare providers on the medicine and its use. 

 {Photo: HEAL TB Ethiopia}Aster Gemede and her daughter, Lemlem, at a TB clinic in Borena.Photo: HEAL TB Ethiopia

Aster Gemede lost her husband to tuberculosis (TB) meningitis early in 2012. Struck with grief, Gemede did not notice her own deteriorating health in the months after his death. Cough, fever, chest pain, and loss of appetite became part of her everyday life. She hardly noticed she was losing weight. When Gemede got to the point where she was unable to look after her two children, she was forced to walk eight hours from her home in rural Borena zone, Oromia, Ethiopia, to the nearest health facility.  

 {Photo credit: MSH}Dagnachew Hailemariam, Head Pharmacist at Bishoftu Hospital.Photo credit: MSH

Dagnachew Hailemariam has worked at Bishoftu General Hospital for six years. The hospital, located 45 km south of Addis Ababa in the town of Bishoftu, is state owned and provides services to between 400 and 500 patients per day. Likewise, the hospital pharmacy receives orders for around 400 to 500 prescriptions per day.

 {Photo credit: Berhan Teklehaimanot/MSH}HEAL TB has trained 471 district TB focal persons on identification and management of TB in children in the Amhara and Oromia regions of Ethiopia.Photo credit: Berhan Teklehaimanot/MSH

The World Health Organization (WHO) estimates that up to 80,000 children die from tuberculosis (TB) each year and that children account for over half a million new cases annually. Unfortunately, global figures likely underestimate the burden of childhood TB worldwide due to missed diagnosis, causing TB in children to be a ‘’hidden epidemic.”

 {Photo credit: MSH}Meleakeselam Kahilayu at Teklehaimanot monastery, South Tigray, Ethiopia.Photo credit: MSH

Melakeselam Kalayu is a religious leader who has been conducting baptisms for 15 years at Teklehaimanot Monastery in southern Tigray, Ethiopia. Throughout this time, Kalayu had prohibited people from taking any medications while using holy water at the monastery. Among the thousands of visitors to the monastery every day, many are people living with HIV (PLHIV). In response to Kalayu's teaching, many stopped their antiretroviral therapy (ART) while using holy water at the monastery.

The four-year Ethiopia Network for HIV/AIDS Treatment, Care, and Support (ENHAT-CS) project held its end-of-project conference in December in Addis Ababa, Ethiopia, and announced its notable achievements in the two regions where it operated – Amhara and Tigray.

{Photo credit: Warren Zelman, Ethiopia.}Photo credit: Warren Zelman, Ethiopia.

This story originally appeared on SIAPSProgram.org. This year’s National Annual Review led by Ethiopia’s Ministry of Health (MoH) brought together more than 850 health professionals from across the country to discuss the way forward in public health for the coming year. The MoH identified eight priority areas, one of them being the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program/Ethiopia's transformative APTS system—the first time a pharmacy area was selected as part of the annual review meeting agenda.

Pages

Printer Friendly Version